Join our Community
Support ToI and remove all ads
Learn more
×

antibodies

Prof. Eilat Shinar (left), head of MDA Blood Services speaks to an Israeli donating blood. (Courtesy of Magen David Adom)
September 12, 2023, 12:08 pm
With COVID cases on the rise, Magen David Adom asks public to donate plasma
Donors must meet certain criteria, including COVID illness and recovery within the last several months, so that antibodies will be relevant for newer variants of the virus
By Renee Ghert-Zand
Illustration: Antibodies attacking contagious virus cells (wildpixel; iStock by Getty Images)
February 28, 2023, 5:21 pm
Israel lab backed by pharma giants mints startup for computer-designed antibodies
AION Labs, a consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company to build a computational platform to design live-saving antibodies from scratch
By Sharon Wrobel
Illustrative image: antibodies attacking a cell (Christoph Burgstedt via iStock by Getty Images)
November 20, 2022, 11:10 am
Cancer patients test world’s first ‘computer-designed’ antibodies, made in Israel
‘Nano-robot’ antibodies can be programmed to do much more when designed from scratch than when based on animal/human antibodies, says inventor
By Nathan Jeffay
Former Polish President Alekdander Kwasniewski touches a memorial for slain Jews at a ceremony marking 70 years since Polish villagers murdered hundreds of their Jewish neighbors during World War II, in Jedwabne, Poland, July 10, 2011. (AP Photo/Czarek Sokolowski)
September 12, 2022, 1:51 pm
Daily Briefing Sept. 12: Poland seeks WWII reparations – for Jews killed by Poles
Diaspora reporter Judah Ari Gross delves into a shocking story out of Poland; health reporter Nathan Jeffay brings us the latest in COVID research and a cancer detection blood test
By ToI Staff
A computer-generated image of the synthetic cancer-fighting molecule developed at Tel Aviv University encountering proteins that inhibit the immune system. After encountering the proteins it reprograms them, to enable the immune system to fight the tumor. (courtesy of Tel Aviv University)
August 10, 2022, 11:52 am
Israeli scientists racing to deliver world’s 1st pill-form immunotherapy for cancer
Cancer patients currently need to visit a hospital for treatment; Israeli-Portuguese research could change this, scientists say, although potential drug years away
By Nathan Jeffay
Illustrative image: An Israeli soldier conducts a COVID-19 antibody test on a boy in Hadera, Israel, Monday, August 23, 2021. (AP Photo/Ariel Schalit)
July 29, 2022, 1:33 pm
Can you judge your COVID immunity with an antibody test? Israeli research says yes
Team says such tests could be used as a screening tool for the allocation of the first batches of updated vaccines, once these arrive
By Nathan Jeffay
Illustrative image: A surgeon dressing a wound (Katarzyna Bialasiewicz; iStock by Getty Images)
July 11, 2022, 12:58 pm
Israeli study: Chemical heals wounds twice as fast, could be antibiotic alternative
Researchers say ointment could become standard medication, but long path ahead; chemical ‘jams’ communication between bacteria at injury site, making healing easier
By Nathan Jeffay
A member of the medical staff and a patient on the coronavirus ward of Kaplan Medical Center in Rehovot on January 18, 2022. (Yossi Aloni/Flash90)
January 21, 2022, 11:16 am
Two months since Omicron emerged, where does Israel stand? Q&A with an expert
Did the travel ban help? Why aren’t vaccines working the same as with previous variants? Why don’t antibody counts tell us if we’re protected? Immunologist Dr. Yariv Wine answers
By Nathan Jeffay
A Regeneron monoclonal antibody infusion bag is seen at a hospital in Fort Lauderdale, Florida, August 19, 2021. (Joe Cavaretta/ South Florida Sun-Sentinel via AP, File)
December 19, 2021, 10:23 pm
US doctors warn Omicron may sideline two leading anti-COVID drugs
Virologist predicts shortage of GlaxoSmithKline’s drug, the only one that remains effective, after Regeneron, Eli Lilly say their therapies appear less useful against new strain
By MATTHEW PERRONE
Undated photo provided in December 2021 by AstraZeneca shows its Evusheld anti-body medication. (AstraZeneca via AP)
December 9, 2021, 11:44 am
FDA approves new COVID-19 antibody drug to protect most vulnerable from coronavirus
AstraZeneca’s Evusheld okayed for those 12 and older who didn’t respond adequately to vaccines or who have history of severe allergic reactions to shots
By Agencies
Illustrative: Antibodies attacking a SARS-CoV-2 virus (Dr_Microbe;iStock by Getty Images)
October 7, 2021, 4:37 am
Israeli research shows clear antibody drop 6 months after 2nd vaccine dose
Study followed 5,000 medical personnel who were under observation after getting first two shots
By ToI Staff
A vial of Pfizer-Biontech COVID-19 vaccine is seen at a Clalit health clinic in Jerusalem on August 8, 2021. (Olivier Fitoussi/Flash90)
September 23, 2021, 4:45 am
Israel, Pfizer said to extend expiration date of some 60,000 vaccine doses
Meanwhile, country to widely administer synthetic antibody treatment to COVID-19 patients, prioritizing the unvaccinated
By ToI Staff
Israelis wait to recieve a COVID-19 vaccine, at a vaccination center operated by the Tel Aviv Municipality with Tel Aviv Sourasky Medical Center (Ichilov), at Rabin Square in Tel Aviv, December 31, 2020. (Miriam ALster/Flash90)
July 14, 2021, 6:53 pm
Israeli research finds COVID-19 antibody levels differ between men and women
Age also a major factor in immune response, according to study, which could lead to targeted treatment based on biological sex
By Stuart Winer
Pascal Soriot, Executive Director and Chief Executive Officer of AstraZeneca, on Capitol Hill in Washington, February 26, 2019. (Jacquelyn Martin/AP)
March 16, 2021, 11:39 am
AstraZeneca boosts planned US supply of COVID-19 antibody drug
British pharmaceutical giant, whose coronavirus vaccine faces European safety doubts, announces it will provide 700,000 doses of a potential treatment for virus
By AFP
A man donates plasma at the Jewish Children's Museum plasma drive, Brooklyn, New York, January 27, 2021. (Courtesy/Anash.org)
February 12, 2021, 9:10 pm
Grassroots Orthodox effort in NY helps bring antibody treatment into mainstream
In early 2020, donors recruited by the Covid Plasma Initiative supplied 50% of the nation’s plasma, also demonstrating the treatment’s efficacy and paving the way to widespread use
By Cathryn J. Prince
Load More

Sign in or Join The Times of Israel Community

Sign in or Register

Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Sign in or Register
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.